Qiagen (QGEN) Cost of Revenue (2009 - 2025)

Qiagen (QGEN) has 17 years of Cost of Revenue data on file, last reported at $200.2 million in Q4 2025.

• Quarterly Cost of Revenue rose 14.82% year-over-year to $200.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $571.0 million (down 29.02% YoY) and the FY2025 annual result came in at $790.5 million, up 75.31% from the prior year.
• Cost of Revenue climbed to $200.2 million in Q4 2025 per QGEN's latest filing, from $187.8 million in the prior quarter.
• The five-year high for Cost of Revenue was $298.6 million in Q2 2024, with the low at $21.7 million in Q2 2025.
• Average Cost of Revenue over 5 years is $173.3 million, with a median of $174.4 million recorded in 2024.
• Year-over-year, Cost of Revenue surged 79.18% in 2024 and slumped 92.73% in 2025.
• Qiagen's Cost of Revenue stood at $193.1 million in 2021, then slipped by 14.33% to $165.5 million in 2022, then gained by 6.98% to $177.0 million in 2023, then retreated by 1.48% to $174.4 million in 2024, then increased by 14.82% to $200.2 million in 2025.
• Business Quant data shows QGEN's Cost of Revenue at $200.2 million in Q4 2025, $187.8 million in Q3 2025, and $21.7 million in Q2 2025.